StonvexLoading…
StonvexStonvexStonvexCore line items from MD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.91B | $2.01B | $1.99B | $1.97B |
Operating Income | $208.81M | $-68.71M | $7.32M | $172.69M |
Net Income | $165.39M | $-99.07M | $-60.41M | $66.33M |
EPS (Diluted) | $1.94 | $-1.19 | $-0.73 | $0.79 |
Total Assets | $2.25B | $2.15B | $2.22B | $2.35B |
Total Liabilities | $1.38B | $1.39B | $1.37B | $1.46B |
Cash & Equivalents | $375.24M | $229.94M | $73.26M | $9.82M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 82.98M | 85.87M | 84.02M | 82.95M |